Search for: "Barr, in Re" Results 901 - 920 of 1,036
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2009, 1:27 am
Vaccines aren't as profitable as other drugs for manufacturers, and without protection against lawsuits "they're saying, 'Do we need this? [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
1 Jul 2009, 12:38 am
The foundation's complaint names Womble and former Womble attorney Howard Barr as defendants. [read post]
19 Jun 2009, 8:21 am
Today’s Merits Decisions Pastor Rick Barr and Philemon Homes, Inc. v. [read post]
18 Jun 2009, 5:19 pm
Denial of habeas corpus (11th Circuit) Petition for certiorari Brief in opposition Brief amici curiae of Bob Barr, et al., Former Prosecutors and Members of the Judiciary(in support of petitioner) Cases involving lawyers from Akin Gump or Howe & Russell (listed without regard to likelihood of being granted): Docket: 08-1200 Title: Jerman, v. [read post]
11 Jun 2009, 9:14 am
House of Representatives, Barr - a former federal prosecutor - helped craft the act. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
28 May 2009, 7:06 am
In a recent post about this topic, Jason Barr wrote the following: I realized I had to be willing to fail in order to succeed. [read post]
25 May 2009, 7:15 pm
"It's hard to get around the fact we're in an unprecedented economic downturn," he said. [read post]
23 May 2009, 12:12 am
It's absolutely chilling that we're willing to do it when we're not even sure we've got the right person in our clutches.Mr. [read post]
20 May 2009, 5:18 am
BIO Policy Briefing raises the IP social media question (PatentlyBIOtech) Vietnam: Patentability of medical use claims in Vietnam (RelatIP)   Products Actonel (Risedronic) – US: CAFC affirms Procter & Gamble’s Actonel patent validity; nonobviousness of positional isomer: Procter & Gamble v Teva (Patent Docs) (Patently-O) (SmartBrief) (SmartBrief) (GenericsWeb) Alimta (Pemetrexed) – US: Eli Lilly and Princeton University sue Barr… [read post]
5 May 2009, 5:57 am
District Court, Southern District of Indiana (Indianapolis); and In re Seroquel Products Litigation, 06-MD-01769, U.S. [read post]
19 Apr 2009, 1:58 am
"They're the two arguments that I think will have the most success even though they're the least sexy," she said. [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]